European Commission approves Genzyme’s multiple sclerosis treatment Lemtrada™ (alemtuzumab)
Genzyme, 17 Sep 2013
Accessed on 17 Sep 2013 from http://news.genzyme.com/press-release/european-commission-approves-genzymes-multiple-sclerosis-treatment-lemtrada-alemtuzuma.